Literature DB >> 25941552

Decaprenylphosphoryl-β-d-ribose 2'-Epimerase 1 (DprE1): A Novel Therapeutic Target for the Treatment of Tuberculosis.

Ahmed F Abdel-Magid1.   

Abstract

Entities:  

Year:  2015        PMID： 25941552      PMCID： PMC4416437          DOI： 10.1021/acsmedchemlett.5b00080

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN： 1948-5875            Impact factor:   4.345


× No keyword cloud information.
  3 in total

Review 1.  New tuberculosis drugs on the horizon.

Authors:  Stewart T Cole; Giovanna Riccardi
Journal:  Curr Opin Microbiol       Date:  2011-08-05       Impact factor: 7.934

Review 2.  The DprE1 enzyme, one of the most vulnerable targets of Mycobacterium tuberculosis.

Authors:  Giovanna Riccardi; Maria Rosalia Pasca; Laurent Roberto Chiarelli; Giulia Manina; Andrea Mattevi; Claudia Binda
Journal:  Appl Microbiol Biotechnol       Date:  2013-09-14       Impact factor: 4.813

Review 3.  DprE1--from the discovery to the promising tuberculosis drug target.

Authors:  Katarína Mikusová; Vadim Makarov; João Neres
Journal:  Curr Pharm Des       Date:  2014       Impact factor: 3.116
  3 in total
  1 in total

1.  Metabolism of SKLB-TB1001, a Potent Antituberculosis Agent, in Animals.

Authors:  Lu Xiong; Chao Gao; Yao-Jie Shi; Xin Tao; Cui-Ting Peng; Juan Rong; Kun-Lin Liu; Qian Lei; Yi-Wen Zhang; Ning-Yu Wang; Luo-Ting Yu
Journal:  Antimicrob Agents Chemother       Date:  2018-06-26       Impact factor: 5.191
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.